🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Egypt / NCT07610876
Recruiting Not applicable

Autologous Demineralized Dentin Graft With or Without Melatonin for Immediate Implant Osseointegration

NCT07610876 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2025-08-11
Last updated
2026-08-26

Condition(s) studied

Dental ImplantsImmediate Implant PlacementOsseointegration

Investigational drug(s) / intervention(s)

Autologous Demineralized Dentin GraftMelatonin gel →

Autologous Demineralized Dentin Graft: Autologous demineralized dentin graft prepared from extracted non-restorable teeth will be used for filling the jumping gap around immediately placed dental implants. Tooth preparation includes removal of restorations, caries, periodontal ligament, pulp tissue, calculus, and cementum, followed by grinding and demineralization using 2% nitric acid before graft placement.

Melatonin gel: Melatonin gel will be mixed with autologous demineralized dentin graft and used for filling the jumping gap around immediately placed dental implants in the maxillary premolar region to enhance osseointegration and peri-implant bone healing.

Study summary

This randomized clinical study aims to evaluate the effect of autologous demineralized dentin graft (ADDG) with or without melatonin gel on the osseointegration of immediately placed dental implants in the maxillary premolar region. Thirty patients requiring extraction and immediate implant placement will be randomly allocated into two groups. Clinical and radiographic outcomes including implant stability, peri-implant probing depth, modified bleeding index, marginal bone loss, buccal bone thickness, and bone density will be evaluated over a 9-month follow-up period.

Eligibility

Sex
ALL
Min age
20 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Age above 20 years * Non-restorable maxillary premolar teeth * Candidates for immediate implant placement * Intact socket walls * Jumping gap \>2 mm * Non-smokers or light smokers * No acute infection * Adequate bone for primary stability Exclusion Criteria: * Heavy smokers * Bruxism or clenching * Uncontrolled systemic disease * Chemotherapy/radiotherapy * Immunocompromised patients

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Suez Canal University, Faculty of Dentistry Ismailia Egypt Recruiting

More Suez Canal University trials in Egypt

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07610876 on ClinicalTrials.gov ↗ ← All trials in Egypt